Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000354343

Medchemexpress LLC Ono-8430506 | 1354805-08-5 | 99.9% | C27H28FN3O3 | 50 MG
SDP

Catalog No. 5000354343
Encompass_Preferred

This orally bioavailable and potent autotaxin (ATX)/ENPP2 inhibitor efficiently inhibits lysophosphatidic acid (LPA) formation with IC50s of approximately 10 nM. In vivo, it slows initial tumor growth, limits lung metastasis in mice, and enhances the antitumor effect of Paclitaxel in a breast cancer model. This product is for research use only.

  • Potent autotaxin (ATX)/ENPP2 inhibitor
  • Orally bioavailable
  • Efficiently inhibits lysophosphatidic acid (LPA) formation
  • Slows initial tumor growth and limits lung metastasis
  • Enhances antitumor effect of Paclitaxel in breast cancer models

Catalog No. 50-003-54343 Supplier Medchemexpress LLC Supplier No. HY14534450MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

This orally bioavailable and potent autotaxin (ATX)/ENPP2 inhibitor efficiently inhibits lysophosphatidic acid (LPA) formation with IC50s of approximately 10 nM. In vivo, it slows initial tumor growth, limits lung metastasis in mice, and enhances the antitumor effect of Paclitaxel in a breast cancer model. This product is for research use only.

  • Potent autotaxin (ATX)/ENPP2 inhibitor
  • Orally bioavailable
  • Efficiently inhibits lysophosphatidic acid (LPA) formation
  • Slows initial tumor growth and limits lung metastasis
  • Enhances antitumor effect of Paclitaxel in breast cancer models

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.